**Core Concept:** Beta-2 microglobulin is a small protein that plays a role in immune response and is a component of high-density lipoprotein (HDL) particles in plasma. Its elevation can indicate the presence of certain malignant cells and is associated with renal dysfunction.

**Why the Correct Answer is Right:** Beta-2 microglobulin is primarily associated with **Amyotrophic Lateral Sclerosis (ALS)**. In this neurodegenerative disease, elevated levels of beta-2 microglobulin are indicative of the disease progression and can be used as a marker to monitor the disease status. Additionally, its elevation can also reflect renal dysfunction, which is commonly seen in patients with ALS due to amyloid angiopathy and amyloidosis.

**Why Each Wrong Option is Incorrect:**

A. **Multiple Myeloma:** Though multiple myeloma is a plasma cell disorder, the primary tumor marker for this disease is **Bence Jones proteins** rather than beta-2 microglobulin.

B. **Neuroendocrine tumors:** While beta-2 microglobulin can be elevated in certain neuroendocrine tumors, it is not a specific tumor marker for this disease, making C the correct choice.

C. **Amyotrophic Lateral Sclerosis (ALS)**: As mentioned above, beta-2 microglobulin is a specific marker for ALS progression and renal dysfunction.

D. **Neuroendocrine tumors:** Beta-2 microglobulin can be elevated in certain neuroendocrine tumors, but it is not a specific marker for these tumors, making D the correct choice.

**Clinical Pearl:** Beta-2 microglobulin is also used as a marker for kidney function and dialysis, but the question specifically asks for a tumor marker, making C the correct answer in this context.

**Correct Answer:** C. Amyotrophic Lateral Sclerosis (ALS)